1. Home
  2. PERF vs DRUG Comparison

PERF vs DRUG Comparison

Compare PERF & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PERF
  • DRUG
  • Stock Information
  • Founded
  • PERF 2015
  • DRUG 2019
  • Country
  • PERF Taiwan
  • DRUG United States
  • Employees
  • PERF N/A
  • DRUG N/A
  • Industry
  • PERF Computer Software: Prepackaged Software
  • DRUG Pharmaceuticals and Biotechnology
  • Sector
  • PERF Technology
  • DRUG Health Care
  • Exchange
  • PERF Nasdaq
  • DRUG Nasdaq
  • Market Cap
  • PERF 191.5M
  • DRUG 345.6M
  • IPO Year
  • PERF N/A
  • DRUG N/A
  • Fundamental
  • Price
  • PERF $2.07
  • DRUG $48.75
  • Analyst Decision
  • PERF Buy
  • DRUG Strong Buy
  • Analyst Count
  • PERF 1
  • DRUG 9
  • Target Price
  • PERF $5.00
  • DRUG $81.67
  • AVG Volume (30 Days)
  • PERF 147.3K
  • DRUG 72.8K
  • Earning Date
  • PERF 10-28-2025
  • DRUG 08-11-2025
  • Dividend Yield
  • PERF N/A
  • DRUG N/A
  • EPS Growth
  • PERF 4.30
  • DRUG N/A
  • EPS
  • PERF 0.06
  • DRUG N/A
  • Revenue
  • PERF $64,369,000.00
  • DRUG N/A
  • Revenue This Year
  • PERF $15.84
  • DRUG N/A
  • Revenue Next Year
  • PERF $14.54
  • DRUG N/A
  • P/E Ratio
  • PERF $34.65
  • DRUG N/A
  • Revenue Growth
  • PERF 13.19
  • DRUG N/A
  • 52 Week Low
  • PERF $1.51
  • DRUG $0.94
  • 52 Week High
  • PERF $3.44
  • DRUG $79.02
  • Technical
  • Relative Strength Index (RSI)
  • PERF 55.18
  • DRUG 66.11
  • Support Level
  • PERF $1.88
  • DRUG $39.70
  • Resistance Level
  • PERF $1.97
  • DRUG $46.44
  • Average True Range (ATR)
  • PERF 0.09
  • DRUG 3.25
  • MACD
  • PERF 0.01
  • DRUG 0.20
  • Stochastic Oscillator
  • PERF 70.32
  • DRUG 93.56

About PERF Perfect Corp.

Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: